CHMP to discuss benefit-risk with patients

6 October 2014 - Deborah Wilkes

Archived

The European Medicines Agency (EMA) has launched a pilot project to involve patients in assessments of the benefits and risks of medicines by its Committee for Medicinal Products for Human Use (CHMP).

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: